Half of the total population is female, yet women’s health – especially in the field of medtech – has often played a secondary role until now. But some companies have already recognized the huge market potential for specialized software solutions, apps and health applications: The femtech (female technology) sector is growing inexorably, and with it the range of services that support women in a digital way, when they have health care questions or problems related to their health.
MyIUS is one of these service apps. As a certified Class I product, MyIUS accompanies users of a hormonal IUS. With the app, menstruation can be tracked and thus a prediction of the bleeding profile for 6 months can be made.
The app, initiated by the pharmaceutical company Bayer, was developed by BAYOOMED GmbH and launched on the market by BAYOOCARE GmbH as legal manufacturer.